Categories: Health

Orion Corporation: Managers transactions Liisa Hurme

 | Source: Orion Oyj

ORION CORPORATION
MANAGERS’ TRANSACTIONS
11 MARCH 2025 at 09.00 EET
        

Orion Corporation: Managers’ transactions – Liisa Hurme

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj – Managers’ Transactions
____________________________________________
Person subject to the notification requirement
Name: Liisa Hurme
Position: Chief Executive Officer
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 99372/4/4

____________________________________________
Transaction date: 2025-03-10
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 17000 Unit price: 0 EUR

Aggregated transactions (1):
Volume: 17000 Volume weighted average price: 0 EUR

Orion Corporation

Liisa Hurme

President and CEO

Olli Huotari

Executive Vice President,
Corporate Functions

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orionpharma.com

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion’s net sales in 2024 amounted to EUR 1,542 million and the company had about 3,700 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.

GlobeNews Wire

Recent Posts

QuisLex Releases Upcoming Event Schedule

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- New York, NY – May 7, 2025…

30 minutes ago

Ripple Price Prediction: Analysts Announce Bullish $7$10 XRP Projection for Summer StratoVM Surges 2,939% Amid Market Optimism

ROAD TOWN, British Virgin Islands, May 07, 2025 (GLOBE NEWSWIRE) -- XRP is making headlines…

30 minutes ago

FioBit, The Most Profitable Cloud Mining Platform: Passive Income Made Effortless

London, UK, May 07, 2025 (GLOBE NEWSWIRE) -- Crypto investors everywhere are feeling the tremors,…

30 minutes ago

kama.ai Launches Trustworthy Hybrid AI Agents

TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- kama.ai, a leader in responsible conversational AI solutions,…

30 minutes ago

Best Same Day Loans Online No Credit Check Instant & Guaranteed Approval 2025 – Payday Ventures

HOUSTON, May 07, 2025 (GLOBE NEWSWIRE) -- Payday Ventures, a leading provider of online loans,…

30 minutes ago

Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as…

3 hours ago